132 related articles for article (PubMed ID: 12943889)
1. Relation of albumin/creatinine ratio to C-reactive protein and to the metabolic syndrome.
Messerli AW; Seshadri N; Pearce GL; Sachar R; Hoogwerf BJ; Sprecher DL
Am J Cardiol; 2003 Sep; 92(5):610-2. PubMed ID: 12943889
[TBL] [Abstract][Full Text] [Related]
2. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Diabetes Care; 2005 Oct; 28(10):2525-30. PubMed ID: 16186291
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
4. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome.
Ahmadnezhad M; Arefhosseini SR; Parizadeh MR; Tavallaie S; Tayefi M; Darroudi S; Ghazizadeh H; Moohebati M; Ebrahimi M; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mogharebzadeh V; Ghayour-Mobarhan M
Biofactors; 2018 May; 44(3):263-271. PubMed ID: 29638023
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C, CRP, log TG/HDLc and metabolic syndrome are associated with microalbuminuria in hypertension.
Moura Rdo S; Vasconcelos DF; Freitas E; Moura FJ; Rosa TT; Veiga JP
Arq Bras Cardiol; 2014 Jan; 102(1):54-9. PubMed ID: 24162470
[TBL] [Abstract][Full Text] [Related]
6. Small, dense LDL and high-sensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus.
Nakano S; Kuboki K; Matsumoto T; Nishimura C; Yoshino G
J Atheroscler Thromb; 2010 Apr; 17(4):410-5. PubMed ID: 20197633
[TBL] [Abstract][Full Text] [Related]
7. Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study.
Vart P; Scheven L; Lambers Heerspink HJ; de Jong PE; de Zeeuw D; Gansevoort RT;
Am J Kidney Dis; 2016 Jan; 67(1):70-8. PubMed ID: 26188433
[TBL] [Abstract][Full Text] [Related]
8. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome.
Darroudi S; Fereydouni N; Tayefi M; Ahmadnezhad M; Zamani P; Tayefi B; Kharazmi J; Tavalaie S; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mohammadpour AH; Esmaily H; Ghayour-Mobarhan M
Biofactors; 2019 Jan; 45(1):35-42. PubMed ID: 30561055
[TBL] [Abstract][Full Text] [Related]
10. [New definition of metabolic syndrome: does it have the same cardiovascular risk?].
Rodilla E; González C; Costa JA; Pascual JM
Rev Clin Esp; 2007 Feb; 207(2):69-74. PubMed ID: 17397565
[TBL] [Abstract][Full Text] [Related]
11. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
Lee E; Lee YK; Kang HJ
Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological data and screening criteria of the metabolic syndrome].
Boulogne A; Vantyghem MC
Presse Med; 2004 Jun; 33(10):662-5, 681. PubMed ID: 15257240
[TBL] [Abstract][Full Text] [Related]
13. Discordant associations of lipid parameters with albuminuria and chronic kidney disease: a population-based study.
Sun K; Lin D; Li F; Huang C; Qi Y; Xue S; Tang J; Yang C; Li Y; Ren M; Yan L
Lipids Health Dis; 2015 Nov; 14():152. PubMed ID: 26607500
[TBL] [Abstract][Full Text] [Related]
14. Comparison of C-reactive protein and albumin excretion as prognostic markers for 10-year mortality after myocardial infarction.
Berton G; Cordiano R; Palmieri R; Cavuto F; Buttazzi P; Palatini P
Clin Cardiol; 2010 Aug; 33(8):508-15. PubMed ID: 20734449
[TBL] [Abstract][Full Text] [Related]
15. Coronary atherogenic risk factors in women.
Stangl V; Baumann G; Stangl K
Eur Heart J; 2002 Nov; 23(22):1738-52. PubMed ID: 12419293
[No Abstract] [Full Text] [Related]
16. Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands.
Gorgels WJ; van der Graaf Y; Hjemdahl P; Kortlandt W; Collette HJ; Erkelens DW; Banga JD
Am J Epidemiol; 1995 Dec; 142(11):1157-64. PubMed ID: 7485062
[TBL] [Abstract][Full Text] [Related]
17. The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community.
Wang Z; Hoy WE; Wang Z
BMC Nephrol; 2013 Aug; 14():176. PubMed ID: 23947772
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.
Malik S; Wong ND; Franklin S; Pio J; Fairchild C; Chen R
Diabetes Care; 2005 Mar; 28(3):690-3. PubMed ID: 15735209
[TBL] [Abstract][Full Text] [Related]
19. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Everett BM; Kurth T; Buring JE; Ridker PM
J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
[TBL] [Abstract][Full Text] [Related]
20. Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker.
Patel AA; Bloomgarden ZT; Futterweit W
Endocr Pract; 2008 Mar; 14(2):193-200. PubMed ID: 18308657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
